NewLink Genetics raises $17M for cancer vaccines, immunomodulation
See our exclusive story on this Ames, Iowa, biotech at VentureBeat Life Sciences.
Next Story: Amazon buys Audible — giving it triple threat of print, digital, audio
Previous Story: Twitter’s struggles harm more than just the users
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.